SCHEMBL20060084

SCHEMBL20060084

CCc1csc([C@H](Cc2ccc(N[SH](=O)=O)cc2)NC(=O)C(Cc2ccccc2)c2ccccc2F)n1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.54
PTPN1 P18031 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21699632 1.00 PTPRB (0.54) PTPRBPTPN1
SCHEMBL20059864 0.89 PTPRB (0.56) PTPRBPTPN1
SCHEMBL20810273 0.89 PTPRB (0.48) PTPRBPTPN1
SCHEMBL500043 0.88 PTPRB (0.71) PTPRBPTPN1
SCHEMBL500042 0.88 PTPRB (0.71) PTPRBPTPN1
SCHEMBL20060125 0.84 PTPRB (0.53) PTPRBPTPN1
SCHEMBL19775508 0.83 PTPRB (0.77) PTPRB
SCHEMBL19775200 0.82 PTPRB (0.75) PTPRB
SCHEMBL19775566 0.82 PTPRB (0.77) PTPRB
SCHEMBL19775219 0.81 PTPRB (0.77) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2967066-B1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES AERPIO THERAPEUTICS INC (US) 2019-10-23 EP disclosed
EP-2385763-B1 METHODS FOR TREATING VASCULAR LEAK SYNDROME AERPIO THERAPEUTICS INC (US) 2018-04-18 EP disclosed